ADAGE CAPITAL PARTNERS GP, L.L.C. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$348,902,000
-21.2%
2,308,014
-24.1%
0.86%
-14.8%
Q2 2022$442,826,000
+1865.7%
3,039,092
+1499.5%
1.02%
+2260.5%
Q1 2022$22,528,000
+42.2%
190,000
+65.2%
0.04%
+48.3%
Q4 2021$15,848,000
+90.1%
115,000
+91.7%
0.03%
+81.2%
Q3 2021$8,335,000
+74.2%
60,000
-14.3%
0.02%
+60.0%
Q1 2021$4,785,000
-62.8%
70,000
-53.3%
0.01%
-64.3%
Q4 2020$12,857,000
-56.1%
150,000
-66.7%
0.03%
-61.6%
Q3 2020$29,255,000
+100.1%
450,000
+125.0%
0.07%
+97.3%
Q2 2020$14,622,000
+118.1%
200,000
+1.5%
0.04%
+85.0%
Q1 2020$6,703,000
-86.3%
196,975
-78.1%
0.02%
-83.3%
Q4 2019$48,996,000
-25.4%
900,000
-42.9%
0.12%
-25.5%
Q3 2019$65,709,000
+17.7%
1,575,000
+23.5%
0.16%
+15.8%
Q2 2019$55,832,000
+60.7%
1,275,000
+88.9%
0.14%
+59.8%
Q1 2019$34,742,000
+87.9%
675,000
+35.0%
0.09%
+70.6%
Q4 2018$18,490,000500,0000.05%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2020
NameSharesValueWeighting ↓
RP Management, LLC 2,111,111$144,294,00054.16%
Knoll Capital Management, LLC 856,844$58,565,00038.16%
ORACLE INVESTMENT MANAGEMENT INC 2,123,271$145,126,00021.73%
KINGDON CAPITAL MANAGEMENT, L.L.C. 860,261$58,799,0006.01%
ARS Investment Partners, LLC 561,442$38,375,0004.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$12,057,0003.19%
Eventide Asset Management 2,015,000$137,725,0002.04%
Avidity Partners Management LP 1,049,800$71,754,0001.98%
SILVERARC CAPITAL MANAGEMENT, LLC 50,089$3,424,0001.87%
Nicholas Investment Partners, LP 375,654$25,676,0001.79%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders